UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 212

Sortiert nach

Treatment of patients with inoperable stage III or stage IV melanoma. Société française de dermatologie

Annales de dermatologie et de vénéréologie, 2018-06, Vol.145 (6-7), p.413-422

2018

Link zum Volltext

Verfügbarkeit prüfen

A randomized, phase II study of afatinib versus cetuximab in metastatic or recurrent squamous cell carcinoma of the head and neck

Annals of oncology, 2014-09, Vol.25 (9), p.1813-1820

2014

Link zum Volltext

Verfügbarkeit prüfen

Traitements locorégionaux de métastase(s) cérébrale(s) chez des patients atteints d’un mélanome cutané métastatique : recommandations nationales françaises

Neuro-chirurgie, 2014-12, Vol.60 (6), p.269-275

2014

Link zum Volltext

Verfügbarkeit prüfen

Les cellules tumorales circulantes arrivent en cancérologie de la tête et du cou

Annales franc̦aises d'oto-rhino-laryngologie et de pathologie cervico-faciale, 2020-06, Vol.137 (3), p.220-220

2020

Link zum Volltext

Verfügbarkeit prüfen

Metastatic angiosarcomas: doxorubicin-based regimens, weekly paclitaxel and metastasectomy significantly improve the outcome

Annals of oncology, 2012-02, Vol.23 (2), p.517-523

2012

Link zum Volltext

Verfügbarkeit prüfen

Prise en charge thérapeutique des patients atteints d’un mélanome cutané métastatique : recommandations nationales françaises

Annales de dermatologie et de vénéréologie, 2014-02, Vol.141 (2), p.111-121

2014

Link zum Volltext

Verfügbarkeit prüfen

Quality of life of patients receiving platinum-based chemotherapy plus cetuximab first line for recurrent and/or metastatic squamous cell carcinoma of the head and neck

Annals of oncology, 2010-10, Vol.21 (10), p.1967-1973

2010

Link zum Volltext

Verfügbarkeit prüfen

A randomized phase III trial comparing trabectedin to best supportive care in patients with pre-treated soft tissue sarcoma: T-SAR, a French Sarcoma Group trial

Annals of oncology, 2021-08, Vol.32 (8), p.1034-1044

2021

Link zum Volltext

Verfügbarkeit prüfen

Imatinib for progressive and recurrent aggressive fibromatosis (desmoid tumors): an FNCLCC/French Sarcoma Group phase II trial with a long-term follow-up

Annals of oncology, 2011-02, Vol.22 (2), p.452-457

2011

Link zum Volltext

Verfügbarkeit prüfen

A phase II of gemcitabine combined with pazopanib followed by pazopanib maintenance, as second-line treatment in patients with advanced leiomyosarcomas: A unicancer French Sarcoma Group study (LMS03 study)

European journal of cancer (1990), 2020-01, Vol.125, p.31-37

2020

Link zum Volltext

Verfügbarkeit prüfen

Traitements systémiques de première et de deuxième lignes des patients atteints d’un mélanome cutané métastatique (hors métastase cérébrale) : Recommandations nationales françaises

Oncologie (Paris, France), 2014, Vol.16 (2-3), p.137-147

2014

Link zum Volltext

Verfügbarkeit prüfen

Effects of lapatinib monotherapy: results of a randomised phase II study in therapy-naive patients with locally advanced squamous cell carcinoma of the head and neck

British journal of cancer, 2011-08, Vol.105 (5), p.618-627

2011

Link zum Volltext

Verfügbarkeit prüfen

Circulating tumour cells in head and neck cancer

European annals of otorhinolaryngology, head and neck diseases, 2020-05, Vol.137 (3), p.235-235

2020

Link zum Volltext

Verfügbarkeit prüfen

TOPNIVO: A safety study of nivolumab in patients with recurrent and/or metastatic platinum-refractory squamous cell carcinoma of the head and neck (R/M SCCHN): First results on behalf of the UNICANCER Head&Neck Group and the GORTEC

Annals of oncology, 2018-10, Vol.29, p.viii380-viii380

2018

Link zum Volltext

Verfügbarkeit prüfen

Extensive limb-sparing surgery with reconstruction for sarcoma of the hand and wrist

Orthopaedics & traumatology, surgery & research, 2016-06, Vol.102 (4), p.467-472

2016

Link zum Volltext

Verfügbarkeit prüfen

A single-arm multicentre phase II trial of doxorubicin in combination with trabectedin in the first-line treatment for leiomyosarcoma with long-term follow-up and impact of cytoreductive surgery

ESMO open, 2021-08, Vol.6 (4), p.100209-100209, Article 100209

2021

Link zum Volltext

Verfügbarkeit prüfen

The ELAN-ONCOVAL (ELderly heAd and Neck cancer-Oncology eValuation) study: Evaluation of the feasibility of a suited geriatric assessment for use by oncologists to classify patients as fit or unfit

Annals of oncology, 2017-09, Vol.28, p.v375-v376

2017

Link zum Volltext

Verfügbarkeit prüfen

Identification of biological factors predictive of response to imatinib mesylate in aggressive fibromatosis

British journal of cancer, 2010-08, Vol.103 (4), p.482-485

2010

Link zum Volltext

Verfügbarkeit prüfen

La chirurgie d’exérèse large conservatrice et reconstructrice des sarcomes au poignet et à la main

Revue de chirurgie orthopédique et traumatologique, 2016-06, Vol.102 (4), p.337-342

2016

Link zum Volltext

Verfügbarkeit prüfen

PO-164: PACSA: Phase II study of pazopanib in patients with progressive recurrent or metastatic salivary gland carcinoma

Radiotherapy and oncology, 2015-02, Vol.114, p.76-77

2015

Link zum Volltext

Verfügbarkeit prüfen

SUN-LB280: Double Blind Multicenter Phase III Gortec Trial Evaluating the Efficacy of Oral Immune Modulating Formulae Therapy During Adjuvant Chemoradiotherapy in Head and Neck Squamous Cell Carcinoma (HNSCC)

Clinical nutrition (Edinburgh, Scotland), 2016-09, Vol.35, p.S148-S149

2016

Link zum Volltext

Verfügbarkeit prüfen

Republication de : Traitements des patients atteints de mélanome de stade III inopérable ou de stade IV. Société française de dermatologie

Bulletin du cancer, 2018-09, Vol.105 (9), p.780-789

2018

Link zum Volltext

Verfügbarkeit prüfen

What is the best management for a spermatic cord sarcoma in 2018?

Progrès en urologie (Paris), 2019-01, Vol.29 (1), p.12-17

2019

Link zum Volltext

Verfügbarkeit prüfen

Quelle prise en charge optimale pour un sarcome du cordon spermatique en 2018 ?

Progrès en urologie (Paris), 2019-01, Vol.29 (1), p.12-17

2019

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 212

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(197)
Mit Volltextzugriff
(182)

Publikationsform

Artikel
(210)
Tagungsberichte
(2)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(92)
Life Sciences & Biomedicine
(79)
Science & Technology
(79)
Male
(66)
Female
(64)
Adult
(63)
Oncology
(63)
Middle Aged
(59)
Aged
(58)
Biological And Medical Sciences
(39)
Medical Sciences
(39)
Pharmacology. Drug Treatments
(32)
Treatment Outcome
(26)
Antineoplastic Agents
(24)
Life Sciences
(23)
Antineoplastic Agents - Adverse Effects
(21)
Chemotherapy
(20)
Aged, 80 And Over
(18)
Antineoplastic Agents - Therapeutic Use
(18)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(17)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Treatment of patients with inoperable stage III or stage IV melanoma. Société française de dermatologie

A randomized, phase II study of afatinib versus cetuximab in metastatic or recurrent squamous cell carcinoma of the head and neck

Prediction of local and metastatic recurrence in solitary fibrous tumor: construction of a risk calculator in a multicenter cohort from the French Sarcoma Group (FSG) database

Traitements locorégionaux de métastase(s) cérébrale(s) chez des patients atteints d’un mélanome cutané métastatique : recommandations nationales françaises

Les cellules tumorales circulantes arrivent en cancérologie de la tête et du cou

Metastatic angiosarcomas: doxorubicin-based regimens, weekly paclitaxel and metastasectomy significantly improve the outcome

Prise en charge thérapeutique des patients atteints d’un mélanome cutané métastatique : recommandations nationales françaises

Quality of life of patients receiving platinum-based chemotherapy plus cetuximab first line for recurrent and/or metastatic squamous cell carcinoma of the head and neck

A randomized phase III trial comparing trabectedin to best supportive care in patients with pre-treated soft tissue sarcoma: T-SAR, a French Sarcoma Group trial

Imatinib for progressive and recurrent aggressive fibromatosis (desmoid tumors): an FNCLCC/French Sarcoma Group phase II trial with a long-term follow-up

A phase II of gemcitabine combined with pazopanib followed by pazopanib maintenance, as second-line treatment in patients with advanced leiomyosarcomas: A unicancer French Sarcoma Group study (LMS03 study)

Traitements systémiques de première et de deuxième lignes des patients atteints d’un mélanome cutané métastatique (hors métastase cérébrale) : Recommandations nationales françaises

Effects of lapatinib monotherapy: results of a randomised phase II study in therapy-naive patients with locally advanced squamous cell carcinoma of the head and neck

Circulating tumour cells in head and neck cancer

TOPNIVO: A safety study of nivolumab in patients with recurrent and/or metastatic platinum-refractory squamous cell carcinoma of the head and neck (R/M SCCHN): First results on behalf of the UNICANCER Head&Neck Group and the GORTEC

Extensive limb-sparing surgery with reconstruction for sarcoma of the hand and wrist

A single-arm multicentre phase II trial of doxorubicin in combination with trabectedin in the first-line treatment for leiomyosarcoma with long-term follow-up and impact of cytoreductive surgery

The ELAN-ONCOVAL (ELderly heAd and Neck cancer-Oncology eValuation) study: Evaluation of the feasibility of a suited geriatric assessment for use by oncologists to classify patients as fit or unfit

Identification of biological factors predictive of response to imatinib mesylate in aggressive fibromatosis

La chirurgie d’exérèse large conservatrice et reconstructrice des sarcomes au poignet et à la main

PO-164: PACSA: Phase II study of pazopanib in patients with progressive recurrent or metastatic salivary gland carcinoma

SUN-LB280: Double Blind Multicenter Phase III Gortec Trial Evaluating the Efficacy of Oral Immune Modulating Formulae Therapy During Adjuvant Chemoradiotherapy in Head and Neck Squamous Cell Carcinoma (HNSCC)

Republication de : Traitements des patients atteints de mélanome de stade III inopérable ou de stade IV. Société française de dermatologie

What is the best management for a spermatic cord sarcoma in 2018?

Quelle prise en charge optimale pour un sarcome du cordon spermatique en 2018 ?

Suchergebnisse filtern